Founded in 2010 by Satyanarayana Vemula, V-Ensure is a developer of speciality pharmaceutical formulations focused on complex generics for regulated markets. Its core competence lies in the development of complex molecules for regulated markets without infringing on any existing patents. The company also specialises in developing strategies to obtain regulatory approvals for the commercialisation of these molecules by end-to-end managing the necessary processes and documentation required by the regulator. V-Ensure claims to have developed solid oral, liquid oral, and injectable products for more than 45 clients across Europe, North America, China, Australia, and Brazil. With a team of over 150 scientists heading pharmaceutical development programmes for major pharmaceutical markets, the company is also solving problems in R&D and manufacturing.